174 related articles for article (PubMed ID: 35812885)
1. A Comparative Field Evaluation of the Effect of Growth Performance Between Porcine Circovirus Type 2a (PCV2a)- and PCV2b-Based Bivalent Vaccines Containing PCV2 and
Cho H; Oh T; Suh J; Chae C
Front Vet Sci; 2022; 9():859344. PubMed ID: 35812885
[TBL] [Abstract][Full Text] [Related]
2. Field evaluation of a sing-dose bivalent vaccine of porcine circovirus type 2b and Mycoplasma hyopneumoniae.
Yang S; Ahn Y; Oh T; Cho H; Park KH; Chae C
Vet Med Sci; 2021 May; 7(3):755-765. PubMed ID: 33386664
[TBL] [Abstract][Full Text] [Related]
3. Comparative growth performance of 3 types of combination vaccines containing porcine circovirus 2 and
Yang S; Lee JY; Oh T; Park KH; Cho H; Suh J; Min KD; Ham HJ; Chae C
Can J Vet Res; 2022 Apr; 86(2):93-101. PubMed ID: 35388232
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Growth Performance between Bivalent and Trivalent Vaccines Containing Porcine Circovirus Type 2 (PCV2) and
Um H; Yang S; Oh T; Park K; Cho H; Suh J; Min KD; Chae C
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34063582
[TBL] [Abstract][Full Text] [Related]
5. Experimental efficacy of a trivalent vaccine containing porcine circovirus types 2a/b (PCV2a/b) and Mycoplasma hyopneumoniae against PCV2d and M. hyopneumoniae challenges.
Yang S; Oh T; Park KH; Cho H; Suh J; Chae C
Vet Microbiol; 2021 Jul; 258():109100. PubMed ID: 33984792
[TBL] [Abstract][Full Text] [Related]
6. A field efficacy trial of a trivalent vaccine containing porcine circovirus type 2a and 2b, and Mycoplasma hyopneumoniae in three herds.
Um H; Yang S; Oh T; Cho H; Park KH; Suh J; Chae C
Vet Med Sci; 2022 Mar; 8(2):578-590. PubMed ID: 34687172
[TBL] [Abstract][Full Text] [Related]
7. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
Yang S; Park SJ; Oh T; Cho H; Chae C
Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
[TBL] [Abstract][Full Text] [Related]
9. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and
Ham S; Suh J; Oh T; Kim C; Seo BJ; Chae C
Front Vet Sci; 2023; 10():1176091. PubMed ID: 37565086
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of bivalent vaccines of porcine circovirus type 2 and
Lim J; Jin M; Yoon I; Yoo HS
J Vet Sci; 2022 May; 23(3):e49. PubMed ID: 35618321
[TBL] [Abstract][Full Text] [Related]
12. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
14. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
[TBL] [Abstract][Full Text] [Related]
15. Virulence Comparison of Four Porcine Circovirus Type 2 (PCV2) Genotypes (2a, 2b, 2d and 2e) in Pigs Single-Infected with PCV2 and Pigs Dual-Infected with PCV2 and Mycoplasma hyopneumoniae.
Oh T; Cho H; Suh J; Chae C
J Comp Pathol; 2022 Nov; 199():88-98. PubMed ID: 36347182
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
[TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
Venegas-Vargas C; Taylor LP; Foss DL; Godbee TK; Philip R; Bandrick M
Vaccine; 2021 Sep; 39(39):5615-5625. PubMed ID: 34420789
[TBL] [Abstract][Full Text] [Related]
18. A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and
Yang S; Oh T; Park KH; Cho H; Chae C
Front Vet Sci; 2020; 7():579. PubMed ID: 32984414
[TBL] [Abstract][Full Text] [Related]
19. Efficacy Evaluation of a Bivalent Vaccine Containing Porcine Circovirus Type 2b and
Ahn Y; Yang S; Oh T; Park KH; Cho H; Suh J; Chae C
Front Vet Sci; 2021; 8():652313. PubMed ID: 33996979
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of intradermal all-in-one vaccine based on an inactivated recombinant Mycoplasma hyopneumoniae strain expressing porcine circovirus type 2 (PCV2) capsid protein against Korean stains of PCV2d and M. hyopneumoniae challenge.
Suh J; Oh T; Chae C
Comp Immunol Microbiol Infect Dis; 2022; 90-91():101911. PubMed ID: 36410070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
